Generics Bulletin is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


France Adds Pfizer's Bevacizumab To Biosimilars List

Executive Summary

Pfizer’s Zirabev biosimilar bevacizumab has been added to France’s list of similar biologics alongside reference brand Avastin by local medicines agency ANSM.


Related Content

France Adds Five Pegfilgrastims To Biosimilar Equivalence List
France trials range of biosimilar incentives
France adds three to similar biologics list
France sets 80% biosimilar goal


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts